Opportunity to acquire a fully licensed German pharmaceutical distributor built for the medical cannabis sector. Operates under a lean, light-touch model using outsourced logistics, compliance, and quality partners, offering a scalable platform for rapid market entry. The entity is pre-revenue with a clean corporate structure and no debt, and is currently fully licensed.
Business Highlights
Licensed, Plug-and-Play Market Entry
- Authorized to register, distribute, and sell medical cannabis products in Germany
- Licences in place provide immediate time-to-market versus a typical 12 to 18 month application timeline (stated)
Lean Operating Model
- Contracts in place with a licensed warehouse and logistics partner for storage and distribution
- Outsourced compliance and quality management structure supports efficient operations
Continuity and Governance
- Appointed Responsible Person for releasing narcotic and medical cannabis products
- Responsible Person is willing to remain with the business under new ownership (stated)
Clean Corporate Profile
- Pre-revenue, no debt, and fully licensed (stated)
- Efficient foundation for scaling into Germany and potentially broader EU channels
Investment Opportunity
Seeking outright divestiture of the licences for €299,000 OBO. Ideal for international producers, distributors, or investors seeking a compliant platform to establish operations in Germany quickly.
